MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics, Inc. (SION)

|||

Balance Sheets Overview

Current Ratio
2004.54%
Quick Ratio
2004.54%
Cash Ratio
587.29%
Debt to Asset Ratio
6.17%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities, current
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liability, noncu...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
63,322
63,324
58,451
50,831
Marketable securities, current
147,709
152,826
177,431
197,498
Prepaid expenses and other current assets
5,099
4,809
5,537
3,999
Total current assets
216,130
220,959
241,419
252,328
Property and equipment, net
1,916
2,071
2,225
2,144
Marketable securities, noncurrent
57,222
73,781
74,420
76,671
Restricted cash
963
963
963
962
Operating lease right-of-use asset
6,424
6,680
6,926
7,165
Other assets
594
585
0
0
Total assets
283,249
305,039
325,953
339,270
Accounts payable
523
2,109
769
1,481
Accrued expenses
8,875
6,328
9,668
6,929
Operating lease liability, current
1,377
1,322
1,269
1,217
Other current liabilities
7
17
6
224
Total current liabilities
10,782
9,776
11,712
9,851
Operating lease liability, noncurrent
6,692
7,055
7,408
7,751
Total liabilities
17,474
16,831
19,120
17,602
Convertible preferred stock, value-Series Seed Convertible Preferred Stock
-
-
0
0
Convertible preferred stock, value-Series AConvertible Preferred Stock
-
-
0
0
Convertible preferred stock, value-Series BConvertible Preferred Stock
-
-
0
0
Convertible preferred stock, value-Series CConvertible Preferred Stock
-
-
0
0
Convertible preferred stock, value
-
-
0
0
Common stock, 0.001 par value, 500,000,000 shares authorized as of june30, 2026 and december31, 2025, respectively 45,164,239 and 44,723,585 shares issued, 45,164,239 and 44,723,585 shares outstanding as of june30, 2026 and december31, 2025, respectively
45
45
45
44
Additional paid-in capital
579,197
571,380
562,602
557,118
Accumulated other comprehensive (loss) income
-448
-84
540
420
Accumulated deficit
-313,019
-283,133
-256,354
-235,914
Total stockholders equity
265,775
288,208
306,833
321,668
Total liabilities and stockholders equity
283,249
305,039
325,953
339,270
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities,current$147,709K (-33.34%↓ Y/Y)Cash and cashequivalents$63,322K (54.50%↑ Y/Y)Prepaid expenses andother current assets$5,099K (22.13%↑ Y/Y)Total current assets$216,130K (-18.98%↓ Y/Y)Marketable securities,noncurrent$57,222K (-23.40%↓ Y/Y)Operating leaseright-of-use asset$6,424K (-13.13%↓ Y/Y)Property and equipment,net$1,916K (-14.69%↓ Y/Y)Restricted cash$963K (0.10%↑ Y/Y)Other assets$594K Total assets$283,249K (-19.54%↓ Y/Y)Total liabilities andstockholders equity$283,249K (-19.54%↓ Y/Y)Total stockholdersequity$265,775K (-21.00%↓ Y/Y)Total liabilities$17,474K (11.88%↑ Y/Y)Accumulated deficit-$313,019K (-45.16%↓ Y/Y)Accumulated othercomprehensive (loss) income-$448K (-344.81%↓ Y/Y)Additional paid-in capital$579,197K (4.96%↑ Y/Y)Total currentliabilities$10,782K (42.81%↑ Y/Y)Operating leaseliability, noncurrent$6,692K (-17.07%↓ Y/Y)Common stock, 0.001 parvalue, 500,000,000...$45K (2.27%↑ Y/Y)Accrued expenses$8,875K (62.31%↑ Y/Y)Operating leaseliability, current$1,377K (17.89%↑ Y/Y)Accounts payable$523K (-42.78%↓ Y/Y)Other currentliabilities$7K